Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · IEX Real-Time Price · USD
3.00
+0.06 (2.04%)
Sep 29, 2023, 10:26 AM EDT - Market open
Relmada Therapeutics Market Cap
Relmada Therapeutics has a market cap or net worth of $90.30 million as of September 29, 2023. Its market cap has decreased by -89.95% in one year.
Market Cap
90.30M
Enterprise Value
-23.72M
1-Year Change
-89.95%
Ranking
Category
Stock Price
$3.00
Market Cap Chart
Since September 30, 2015, Relmada Therapeutics's market cap has increased from $56.60M to $90.30M, an increase of 59.54%. That is a compound annual growth rate of 6.01%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 28, 2023 | 88.50M | -6.65% |
Sep 27, 2023 | 94.80M | - |
Sep 26, 2023 | 94.80M | 1.61% |
Sep 25, 2023 | 93.30M | 11.07% |
Sep 22, 2023 | 84.00M | -2.78% |
Sep 21, 2023 | 86.40M | -3.03% |
Sep 20, 2023 | 89.10M | 6.07% |
Sep 19, 2023 | 84.00M | -5.72% |
Sep 18, 2023 | 89.10M | -4.19% |
Sep 15, 2023 | 93.00M | -6.63% |
Sep 14, 2023 | 99.60M | -0.60% |
Sep 13, 2023 | 100.20M | -1.67% |
Sep 12, 2023 | 101.90M | -0.97% |
Sep 11, 2023 | 102.90M | -3.74% |
Sep 8, 2023 | 106.90M | - |
Sep 7, 2023 | 106.90M | -3.26% |
Sep 6, 2023 | 110.50M | -2.90% |
Sep 5, 2023 | 113.80M | -0.26% |
Sep 1, 2023 | 114.10M | 12.19% |
Aug 31, 2023 | 101.70M | - |
Aug 30, 2023 | 101.70M | 1.19% |
Aug 29, 2023 | 100.50M | -3.74% |
Aug 28, 2023 | 104.40M | 6.42% |
Aug 25, 2023 | 98.10M | 2.19% |
Aug 24, 2023 | 96.00M | 8.84% |
View and export this data all the way back to 2015.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
DiaMedica Therapeutics | 99.43M |
PhenomeX | 98.50M |
Genenta Science | 98.23M |
Cara Therapeutics | 96.80M |
Armata Pharmaceuticals | 96.46M |
Renalytix | 94.06M |
Burning Rock Biotech | 93.96M |
Achieve Life Sciences | 93.50M |